JP2018521992A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018521992A5 JP2018521992A5 JP2017565934A JP2017565934A JP2018521992A5 JP 2018521992 A5 JP2018521992 A5 JP 2018521992A5 JP 2017565934 A JP2017565934 A JP 2017565934A JP 2017565934 A JP2017565934 A JP 2017565934A JP 2018521992 A5 JP2018521992 A5 JP 2018521992A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- wiping
- skin
- cloth
- applying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 71
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 26
- 210000003491 Skin Anatomy 0.000 claims description 23
- 235000011399 aloe vera Nutrition 0.000 claims description 17
- 230000002708 enhancing Effects 0.000 claims description 14
- 229960000458 Allantoin Drugs 0.000 claims description 13
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 13
- 210000001519 tissues Anatomy 0.000 claims description 13
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2S,3R,4S,5S,6R)-2-[(2R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 claims description 11
- 229920002498 Beta-glucan Polymers 0.000 claims description 11
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 10
- 240000005513 Aloe vera Species 0.000 claims description 10
- 229940046009 Vitamin E Drugs 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- 239000003974 emollient agent Substances 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 8
- 210000000987 Immune System Anatomy 0.000 claims description 7
- 230000000845 anti-microbial Effects 0.000 claims description 7
- 239000003623 enhancer Substances 0.000 claims description 7
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 210000004400 Mucous Membrane Anatomy 0.000 claims description 5
- 210000002640 Perineum Anatomy 0.000 claims description 5
- 239000002516 radical scavenger Substances 0.000 claims description 5
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- 230000003110 anti-inflammatory Effects 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 210000000434 stratum corneum Anatomy 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 201000009910 diseases by infectious agent Diseases 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 3
- 230000003020 moisturizing Effects 0.000 claims description 3
- -1 polyphenol compounds Chemical class 0.000 claims description 3
- 229940087603 Grape Seed Extract Drugs 0.000 claims description 2
- 229940106796 Pycnogenol Drugs 0.000 claims description 2
- 230000002292 Radical scavenging Effects 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 229940121363 anti-inflammatory agents Drugs 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229920002770 condensed tannin Polymers 0.000 claims description 2
- 235000002532 grape seed extract Nutrition 0.000 claims description 2
- 239000007952 growth promoter Substances 0.000 claims description 2
- 235000018192 pine bark supplement Nutrition 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims 17
- 238000000034 method Methods 0.000 claims 7
- 210000001099 Axilla Anatomy 0.000 claims 5
- 210000003205 Muscles Anatomy 0.000 claims 5
- 230000000875 corresponding Effects 0.000 claims 5
- 210000002414 Leg Anatomy 0.000 claims 4
- 206010010904 Convulsion Diseases 0.000 claims 3
- 230000017531 blood circulation Effects 0.000 claims 3
- 210000000038 chest Anatomy 0.000 claims 3
- 230000036461 convulsion Effects 0.000 claims 3
- 230000002503 metabolic Effects 0.000 claims 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 239000002699 waste material Substances 0.000 claims 3
- 208000008313 Contusions Diseases 0.000 claims 2
- 210000002683 Foot Anatomy 0.000 claims 2
- 210000002700 Urine Anatomy 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000036512 infertility Effects 0.000 claims 2
- 230000001954 sterilising Effects 0.000 claims 2
- 231100000803 sterility Toxicity 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 2-[diamino(3-formamidopropyl)azaniumyl]acetate Chemical compound [O-]C(=O)C[N+](N)(N)CCCNC=O ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 0.000 claims 1
- 229940083828 Bioflavonoid drugs for capillary stabilizing Drugs 0.000 claims 1
- 229940093797 Bioflavonoids Drugs 0.000 claims 1
- 210000001217 Buttocks Anatomy 0.000 claims 1
- 206010073306 Exposure to radiation Diseases 0.000 claims 1
- 210000000474 Heel Anatomy 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010070757 Muscle contusion Diseases 0.000 claims 1
- 206010049816 Muscle tightness Diseases 0.000 claims 1
- 208000000260 Warts Diseases 0.000 claims 1
- 230000002378 acidificating Effects 0.000 claims 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000001747 exhibiting Effects 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000002458 infectious Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 230000001937 non-anti-biotic Effects 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 201000010153 skin papilloma Diseases 0.000 claims 1
- 201000000195 skin tag Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 241001116389 Aloe Species 0.000 description 7
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 229940065115 GRAPEFRUIT EXTRACT Drugs 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 230000000249 desinfective Effects 0.000 description 3
- 241000207199 Citrus Species 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 2
- 229940116224 behenate Drugs 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000010374 citricidal Substances 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N Cocamidopropyl betaine Chemical group CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N Lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 230000003254 anti-foaming Effects 0.000 description 1
- 230000000843 anti-fungal Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001086 cytosolic Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000000899 immune system response Effects 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000015227 regulation of liquid surface tension Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Description
本発明に係る方法の実施において有用な溶液の一例は、ラウリルグルコシド界面活性剤;界面活性作用も有する、消泡剤としてのジメチコン;細胞増殖を促進し、免疫系応答を増強し、吸収を促進し、治癒を促進し、かつ保湿剤または皮膚軟化剤として作用する、抗炎症特性のためのアロエベラ;フリーラジカルを捕捉する能力を含む、アロエと同様の性質のためのアラントイン;保湿剤または皮膚軟化剤として作用する、抗炎症特性のためのコカミドプロピルプロピルベタイン;アロエおよびアラントインと同様の特性ためのベータグルカン;アロエおよびアラントインと同様の多くの特性を有する、Citricidal(登録商標)ブランドのグレープフルーツ抽出物;抗微生物応答も促進し、免疫系を増強する周知の吸収促進剤である、コロイド状銀;フリーラジカル捕捉剤として作用する能力の、保湿剤または皮膚軟化剤としての特性のためのビタミンE;ならびに保湿および皮膚軟化特性のためのグリセリンを含む。 An example of a solution useful in the practice of the method of the present invention is a lauryl glucoside surfactant; dimethicone as a defoamer that also has a surfactant activity; promotes cell proliferation, enhances immune system response, promotes absorption and, promote healing, and act as humectants or emollients, aloe vera for anti-inflammatory properties; humectants or skin; allantoin for including the ability to capture free radicals, similar properties to aloe Cocamidopropylpropyl betaine for anti-inflammatory properties acting as a softener; beta glucan for properties similar to aloe and allantoin; Citricidal® brand grapefruit with many properties similar to aloe and allantoin Extract; a well-known absorption enhancer that also promotes antimicrobial responses and enhances the immune system Colloidal silver; glycerin for and moisturizing and emollient properties; the ability to act as free radical scavengers, Vitamin E for properties as humectants or emollients.
消毒剤および抗微生物剤であって、約4.0〜6.0のpHを有し、抗炎症、消泡、細胞増殖促進、免疫系増強、抗微生物、皮膚への吸収、およびフリーラジカル捕捉の機能を含む、有望な溶液は、アロエ、ジメチコン、アラントイン、コカミドプロピルプロピルベタイン、グレープフルーツ由来のCitricidal(登録商標)ブランドの第4級化合物を含む柑橘系抽出物、コロイド状銀およびビタミンEの混合物;アロエ、ジメチコン、アラントインおよびコロイド状銀またはグレープフルーツ抽出物の混合物;ジメチコン、アラントイン、グレープフルーツ抽出物、コロイド状銀およびビタミンEの混合物;アロエ、ジメチコン、コカミドプロピルベタイン、グレープフルーツ抽出物およびコロイド状銀の混合物;アロエ、ジメチコン、グレープフルーツ抽出物およびコロイド状銀の混合物;ならびにジメチコン、コカミドプロピルベタイン、コロイド状銀およびベータグルカンの混合物を含む。 Disinfectant and antimicrobial agent having a pH of about 4.0 to 6.0, anti-inflammatory, antifoaming, cell growth promotion, immune system enhancement, antimicrobial, skin absorption, and free radical scavenging Promising solutions containing the functions of Aloe, dimethicone, allantoin, cocamidopropylpropyl betaine, citrus extracts containing Citricidal® quaternary compounds from grapefruit, colloidal silver and vitamin E mixture; aloe, dimethicone, a mixture of allantoin and colloidal silver or grapefruit extract; dimethicone, allantoin, grapefruit extract, a mixture of colloidal silver and vitamin E; aloe, dimethicone, Kokamidopuropi behenate Tyne, grapefruit extract and colloidal silver Mixture of aloe, dimethi Including well dimethicone, Kokamidopuropi behenate tines, a mixture of colloidal silver and beta glucan; down, grapefruit extract and mixtures of colloidal silver.
本発明の実施において有用なスキンケアおよびクレンジング剤は、米国特許第6,358,516号明細書に記載されるように、以下の他の成分を含むことができる。
(a)少なくとも1種の界面活性剤。
(b)少なくとも1種の抗炎症剤。
(c)少なくとも1種の消泡剤。
(d)少なくとも1種の細胞増殖促進剤。
(e)少なくとも1種の即効性抗微生物剤であって、前記成分のそれぞれが、皮膚適合性であり、前記組成物の他の成分とは異なり、かつ少なくとも1種の異なる成分は、下記の群から選択される。
(f)免疫系増強剤であって、少なくとも1種の免疫系増強剤が、アロエベラ、ベータグルカン、コロイド状銀またはアラントインである。
(g)吸収促進剤であって、少なくとも1種の吸収促進剤が、ベータグルカン、アロエベラ、またはコロイド状銀である。
(h)保湿剤および皮膚軟化剤であって、少なくとも1種の保湿剤または皮膚軟化剤が、アロエベラ、ビタミンEまたはコカミドプロピルである。
(i)フリーラジカル捕捉剤であって、少なくとも1種のフリーラジカル捕捉剤が、バイオフラボノイド、ポリフェノール化合物、グレープフルーツ由来の第4級化合物、ベータグルカン、アラントイン、ビタミンE、ピクノジェノールまたはブドウ種子抽出物である。
(j)治癒促進剤であって、前記成分が、皮膚に適用されると、素早く空気乾燥して、1ステップの適用で、皮膚を、クレンジングし、治療的に調整し、および処置する、安定で、すすぎ不要の、放射線滅菌可能な組成物を形成するために選択され、少なくとも1種の治癒促進剤が、アロエベラ、アラントインまたはベータグルカンである。
Skin care and cleansing agents useful in the practice of the present invention can include the following other ingredients, as described in US Pat. No. 6,358,516.
(A) at least one surfactant.
(B) at least one anti-inflammatory agent.
(C) At least one antifoaming agent.
(D) At least one cell growth promoter.
(E) at least one immediate-acting antimicrobial agent, each of the components being skin compatible, different from the other components of the composition, and at least one different component comprising: Selected from the group.
(F) an immune system enhancer, at least one immune system enhancing agent is Aloe vera, beta-glucan, colloidal silver or allantoin.
(G) an absorption enhancer, at least one absorption enhancer, beta-glucan, aloe vera or colloidal silver.
(H) a moisturizer and emollient, at least one humectant or emollient is a aloe vera, vitamin E or cocamidopropyl.
(I) a free radical scavenger, wherein at least one free radical scavenger is a bioflavonoid, a polyphenol compound, a quaternary compound derived from grapefruit, beta glucan, allantoin, vitamin E, pycnogenol or grape seed extract is there.
(J) A healing promoter, wherein when the ingredient is applied to the skin, it quickly air drys, cleans, therapeutically adjusts and treats the skin in one step application in, is selected to form unwanted radiation sterilizable rinse composition, of at least one cure accelerator is a aloe vera, allantoin or beta-glucan.
Theraworx(登録商標)ブランドの消毒クレンザーを含む、本発明の実施において使用するための消毒剤溶液は、コロロヘキサドリンおよびアルコールとは違って、顔、粘膜、道または会陰部および直腸領域に対する適用に制限はなく、必要であると思われる限り頻繁に使用し得る。この製剤は、本質的に、広スペクトラムの抗微生物活性、抗酵母特性および抗真菌特性を有する一方で、皮膚に栄養およびうるおいを与え、皮膚のマンテル(mantel)の自然なpHを維持し、皮膚から感染病原体を除菌する場合であってもバリア機能が保持されるように角質層を支援する。抗微生物活性の持続は、約3時間までであることが実証されている。臭気も感染の1つの指標であり、本発明に係る方法の実施により、CAUTIに関連する臭気が低減または除去されることに留意すべきである。細菌細胞死の様式は、結果的に細胞質の内容物が失われ、さらに皮膚または生組織に損傷がない、細胞膜の破壊であると考えられる。柑橘系の抗微生物安定剤、四級アンモニウムカチオンを有する双性イオン性界面活性剤およびコロイド状銀の3つの物質が寄与すると考えられる。製剤は、ビタミンE、アロエベラ、アラントイン、コロイド状銀およびベータグルカン1を含有し、グラム陰性およびグラム陽性の細菌に対して、99.9%超の有効性であると言われている。
Disinfectant solutions for use in the practice of the present invention, including Therawax® brand disinfecting cleansers, unlike colorohexadrine and alcohol, are intended for application to the face, mucous membranes, tract or perineum and rectal areas. There is no limit and it can be used as often as it seems necessary. This formulation inherently has a broad spectrum of antimicrobial activity, anti-yeast and antifungal properties, while nourishing and moisturizing the skin, maintaining the natural pH of the skin mantel, The stratum corneum is supported so that the barrier function is maintained even when the pathogen is sterilized. The duration of antimicrobial activity has been demonstrated to be up to about 3 hours. It should be noted that odor is also an indicator of infection and that the implementation of the method according to the present invention reduces or eliminates the odor associated with CAUTI. The mode of bacterial cell death is thought to be the destruction of the cell membrane resulting in the loss of cytoplasmic content and no damage to the skin or living tissue. Three substances are thought to contribute: citrus antimicrobial stabilizers, zwitterionic surfactants with quaternary ammonium cations, and colloidal silver. Formulation, vitamin E, aloe vera, allantoin, contain colloidal silver and beta glucan 1, against gram-negative and gram-positive bacteria are said to be the effectiveness of greater than 99.9%.
Claims (26)
(a)少なくとも1種の界面活性剤と、(A) at least one surfactant;
(b)少なくとも1種の抗炎症剤と、(B) at least one anti-inflammatory agent;
(c)少なくとも1種の消泡剤と、(C) at least one antifoaming agent;
(d)少なくとも1種の細胞増殖促進剤と、(D) at least one cell growth promoter;
(e)少なくとも1種の即効性抗微生物剤とを含み、前記成分のそれぞれが、皮膚適合性であり、前記組成物の他の成分とは異なるものであり、かつ下記の成分:(E) at least one immediate-acting antimicrobial agent, each of the components being skin compatible, different from the other components of the composition, and the following components:
(f)少なくとも1種の免疫系増強剤であって、アロエベラ、ベータグルカン、コロイド状銀、およびアラントインからなる群より選択される少なくとも1種の免疫系増強剤;(F) at least one immune system enhancer, at least one immune system enhancer selected from the group consisting of aloe vera, beta glucan, colloidal silver, and allantoin;
(g)少なくとも1種の吸収促進剤であって、ベータグルカン、アロエベラ、およびコロイド状銀からなる群より選択される少なくとも1種の吸収促進剤;(G) at least one absorption enhancer selected from the group consisting of beta glucan, aloe vera, and colloidal silver;
(h)少なくとも1種の保湿剤または皮膚軟化剤であって、アロエベラ、ビタミンE、およびコカミドプロピルベタインからなる群より選択される少なくとも1種の保湿剤および皮膚軟化剤;(H) at least one humectant or emollient, at least one humectant and emollient selected from the group consisting of aloe vera, vitamin E, and cocamidopropyl betaine;
(i)少なくとも1種のフリーラジカル捕捉剤であって、バイオフラボノイド、ポリフェノール化合物、グレープフルーツ由来の第4級化合物、ベータグルカン、アラントイン、ビタミンE、ピクノジェノール、およびブドウ種子抽出物からなる群より選択される少なくとも1種のフリーラジカル補足剤;および(I) at least one free radical scavenger selected from the group consisting of bioflavonoids, polyphenol compounds, quaternary compounds from grapefruit, beta-glucan, allantoin, vitamin E, pycnogenol, and grape seed extract At least one free radical scavenger; and
(j)少なくとも1種の治癒促進剤であって、アロエベラ、アラントイン、およびベータグルカンからなる群より選択される少なくとも1種の治療促進剤、(J) at least one healing promoter, at least one therapeutic promoter selected from the group consisting of aloe vera, allantoin, and beta glucan,
からなる群より選択される少なくとも1種の異なる成分とAt least one different component selected from the group consisting of
を含む、組成物。A composition comprising:
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/745,091 US20160158393A1 (en) | 2014-02-21 | 2015-06-19 | Method for Improving Health Outcomes |
US14/745,091 | 2015-06-19 | ||
PCT/US2016/038043 WO2016205620A1 (en) | 2015-06-19 | 2016-06-17 | Method for improving health outcomes |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018521992A JP2018521992A (en) | 2018-08-09 |
JP2018521992A5 true JP2018521992A5 (en) | 2019-08-15 |
Family
ID=56464282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017565934A Pending JP2018521992A (en) | 2015-06-19 | 2016-06-17 | Ways to improve health outcomes |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3310443A1 (en) |
JP (1) | JP2018521992A (en) |
BR (1) | BR112017027349B1 (en) |
CA (1) | CA2989644A1 (en) |
MX (2) | MX2017016911A (en) |
WO (2) | WO2016205620A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2939940C (en) | 2014-02-21 | 2023-10-03 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
CN107737070A (en) * | 2017-11-16 | 2018-02-27 | 东兴市良佳优农林科技有限公司 | Sterilization, skin care hand cleaning liquid |
CN107693457A (en) * | 2017-11-16 | 2018-02-16 | 东兴市良佳优农林科技有限公司 | Itch-stopping shampoo |
JP2021155362A (en) * | 2020-03-27 | 2021-10-07 | 株式会社ナリス化粧品 | Method for inhibiting peroxynitrite activity and screening method for peroxynitrite activity inhibitor |
IT202000021634A1 (en) * | 2020-09-16 | 2020-12-16 | Prete Antonio Del | DEVICE FOR THE ADMINISTRATION OF A SOLUTION WITH POVIDONE IODIUM FOR THE PREVENTION OF EYE INFECTIONS |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU705862B2 (en) * | 1994-02-28 | 1999-06-03 | Incline Technologies, Inc. | Method and system for cleansing the skin |
US6358516B1 (en) * | 1998-08-21 | 2002-03-19 | Norris R. Harod | One-step system for cleansing, conditioning, and treating the skin |
WO2011139794A2 (en) * | 2010-04-27 | 2011-11-10 | St. John's Medical Research Institute | A composition for skin sanitization and protection and method of its use |
US9327029B2 (en) * | 2011-05-05 | 2016-05-03 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
-
2016
- 2016-06-17 MX MX2017016911A patent/MX2017016911A/en unknown
- 2016-06-17 BR BR112017027349-7A patent/BR112017027349B1/en active IP Right Grant
- 2016-06-17 WO PCT/US2016/038043 patent/WO2016205620A1/en active Application Filing
- 2016-06-17 JP JP2017565934A patent/JP2018521992A/en active Pending
- 2016-06-17 EP EP16741722.9A patent/EP3310443A1/en active Pending
- 2016-06-17 CA CA2989644A patent/CA2989644A1/en active Pending
- 2016-06-20 WO PCT/US2016/038409 patent/WO2016205812A1/en active Application Filing
-
2017
- 2017-12-19 MX MX2022005561A patent/MX2022005561A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7486557B2 (en) | Semi-solid composition for preventing bacterial contamination - Patents.com | |
ES2655876T3 (en) | Trigonella foenum-graecum extract | |
CA2608344C (en) | Method and composition for use in preparation of a patient for surgery | |
US6264927B1 (en) | Topical solution and method for the treatment of nail fungus | |
JP2018521992A5 (en) | ||
JP6495183B2 (en) | Compositions and methods for treating surface wounds | |
US20080287392A1 (en) | Wound-Healing Pharmaceutical Compositions in the Form of a Cream Based on Amino Acids and Sodium Hyaluronate | |
WO2011139794A2 (en) | A composition for skin sanitization and protection and method of its use | |
US20100284951A1 (en) | Novel compositions for the treatment of wounds and skin care | |
US20110301118A1 (en) | Methods of treatment utilising glucan formulations | |
CN102614113A (en) | Compound washing-free disinfection gel | |
JP2018521992A (en) | Ways to improve health outcomes | |
CN105767049A (en) | Disinfectant liquid for animals | |
US7438937B2 (en) | Topical burn composition containing Mentha haplocalyx and one or both of Aloe vera and recombinant human epidermal growth factor | |
CN108743911A (en) | A kind of sterilizing curing agent | |
CN103735481A (en) | Antisepsis and anti-inflammation mouth rinse and preparation method thereof | |
RU2326651C1 (en) | Treatment and cosmetic cream for feet care | |
EP3893992A1 (en) | Composition for the use in topical antimicrobial or anti-infective treatment of skin, soft tissue and wounds | |
CN108355130A (en) | It is a kind of to treat psoriasic temperature sensitive type collagen composite antiphlogistic gel spray and preparation method thereof | |
US20160279037A1 (en) | Cosmetic compositions comprising micro-silver and methods of applying the same | |
RU2326652C1 (en) | Treatment and cosmetic cream for hand care | |
CN100450505C (en) | Chinese medicinal ointment for treating beriberi | |
CN106138143A (en) | Pure Chinese medicine burn and scald, bedsore treatment liquid and preparation method thereof | |
KR101447951B1 (en) | atocare healing ball and its manufacturing method | |
KR20100117864A (en) | Pharmaceutical composition for burn treatment |